NCT04788667Completed
Effectiveness of a Health Education Programme for Prevention of Chronic Migraine: A Randomized Clinical Trial
Effectiveness of a Health Education Programme as a Preventive Treatment for Chronic Migraine: A Randomized Clinical Trial
Source: ClinicalTrials.gov · Last updated 29 Jul 2024
Brief summary (registry, in English)
Chronic migraine (CM) is a common and frequent disorder, which has a major impact on the quality of life of migraine sufferers, interfering with physical function, productivity at work, personal life and leisure, lifestyle and psychological well-being. The use of a prophylactic drug treatment is recommended if headache is present more than 8 days per month. In addition, several studies have shown benefits of non-pharmacological interventions such as self-management strategies, manual therapy and exercise. However, no studies have been found that analyse the beneficial effect of a combination of a preventive drug treatment and a health education programme. Thus, this project would offer a service of health education through a telerehabilitation programme for patients with chronic migraine under prophylactic drug treatment. The aim of this study is to compare the combination of a prophylactic drug therapy and a health education programme in the preventive treatment of patients with chronic migraine.based on the hypothesis that a health education program for chronic migraine patients could decrease the number of migraine days.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 48 (actual)
- First submitted
- 4 Mar 2021
- Start date
- 19 Apr 2021
- Primary completion date
- 22 Apr 2024
- Lead sponsor
- Universidad de Zaragoza
- Diseases
- Migraine
- NCT number
- NCT04788667
What you commit to
- Study type: Interventional
- Participants enrolled: 48
- From 19 Apr 2021 to the primary completion date, 22 Apr 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Patients with severe or unstable psychiatric pathology that contraindicates the use of drug treatment.
- Allergic patients or those who show sensitivity to components of the drug treatment.
Other
- Women who are pregnant or breastfeeding.
- Women with menstrual migraine.
- Patients who refuse to sign the informed consent form or to participate in the study.
- Patients who decide not to continue in the study.
Who the study is looking for
- Age range 18-65 years.
- Patients diagnosed with CM following the ICHD-III criteria.
- Patients with migraine onset before the age of 50 years.
- Patients who have been diagnosed with chronic migraine for at least 1 year.
Age in the registry: 18 years to 65 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Hospital Clinico Universitario Lozano Blesa Coordinator of this site? Confirm its status | Zaragoza | Spain | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.